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Background: Non-steroidal anti-inflammatory drugs (NSAIDs) can result in peptic ulcer disease (PUD) which is a
common condition worldwide. The aim of this study was to evaluate the antiulcer properties of (1-(4-hydroxy-
phenyl)-3-m-tolyl-propenone) (HPTP) chalcone in rats using indomethacin as ulcerogenic agent.
Results: None of the rats showed symptoms of kidney and liver toxicity during the term of the study.
Administration of HPTP had decreased the acidity, increased gastric wall mucus and flattening of gastric mucosa
and reducing erosive gastric damage area. HPTP also showed dose dependent increase in SOD, GPx activity and
PGE2 level and decrease MDA. H & E stain showed decreased infiltration of leucocytes with edema of submucosal
layer. PAS staining showed intense uptake of magenta color of gastric wall mucus in rats fed with HPTP, and
immunohistochemical staining of gastric mucosa revealed over-expression of HSP70 protein, down-expression of
Bax protein and over expression of TGF-β in rats administered with HPTP.
Conclusion: This study has revealed that chalcone1-(4-hydroxy-phenyl)-3-m-tolyl-propenone can serve as a safe
and effective antiulcer agent as it has been proved to increase pH and gastric wall mucus, increase GPx, SOD, PGE2,
and decrease MDA level, ultimately, it has also contributes towards the over-expression of HSP protein andTGF-β,
and down-expression of Bax protein.
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Peptic ulcer disease (PUD) is a common condition as
contributes to morbidity and mortality in humans
worldwide. The annual prevalence of PUD is 0.1-0.19%
[1]. Aetiology of PUD is multi-factorial [2]. High acid
secretion and decreased mucosal barrier contribute to
initiation and progression of PUD [1]. The aetiology is
ranging from Helicobacter pylori (H-pylori) infection to
stress, lifestyle characteristics and drugs [3]. One of the
most important drugs that contribute to PUD is non-
steroidal anti-inflammatory drugs (NSAID) [4]. Con-
sumption of NSAIDs is shown to be related to increased
mucosal injury, erosions and gastric and duodenal* Correspondence: ammeen@um.edu.my
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unless otherwise stated.bleeding. This effect is mainly due to the inhibition of
the cyclooxygenase 1 (COX1) resulting in reduced
mucosal defence as well as Thromboxane A2 which regu-
lates platelet aggregation and therefore results in gastric
bleeding [5]. Another mechanism that is well described in
NSAIDs induced gastric injury is the production of react-
ive oxygen species (ROS) [6]. In literatures, several authors
had been reported the use of synthesized compound for
the treatment of gastrointestinal disorders including gas-
tric ulcerogenic damage [7-9].
The main goals of PUD treatment, is firstly to reduce
acid secretion, the hallmark of these medications is the
proton pomp inhibitor (PPI), and secondly to improve
mucosal barrier, including sucralfate and bismuth salts
(cytoprotective agents) [10]. It is also believed that scav-
enging free radicals will also prevent the production of
PUD [6]. After discovery of H-pylori, eradication of thisntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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treatment of PUD [10,11]. Herbal medication and nat-
ural substances were long used for the treatment and
management of PUD. Different herbs and spices have
been introduced, in traditional medicines, as treatments
for PUD. Plant derived medications have long been con-
sidered as safe and effective agents against PUD [12].
Flavonoids are one of the most abundant compart-
ments in the vegetarian kingdom. Flavonoids are found
in any part of plants including leaves, stalks, roots, fruits
and seeds and are proven to have different effects on the
gastrointestinal tract. They are also shown to be effective
in prevention and treatment of PUD [13]. Chalcones are
the precursors of flavonoids in plants. Most chalcones
contain a six-member heterocyclic ring and are consid-
ered the first product of flavonoid synthesis pathway
[14]. Various chalcones have been identified in nature
and synthesized in laboratories and were shown to have
variety of effects including prevention of peptic ulcer
and oxidative stress as well as antibiotic, antifungal and
anti-inflammatory effects [14-16]. Among the variety of
chalcones 38 chalcones were shown to have antiulcer ef-
fects due to increased gastric blood flow and stimulating
mucosal secretion. To the best of our knowledge no
study was performed on the protective effect of chalcone
against ulcers induced by NSAID prescription as well as
the antioxidant properties of this chalcone in NSAID in-
duced gastric injury.
The aim of this study was to identify the effects of chal-
cone (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone) (HPTP)




A single oral administration of (1-(4-hydroxy-phenyl)-3-
m-tolyl-propenone) (HPTP) chalcone at three doses
(250 mg/kg, 500 mg/kg or 1000 mg/kg) did not result any
mortality for 24 hours and no toxic effects and abnormalTable 1 Effects of HPTP on renal function test (male and fema
Male Sodium mmol/L Potassium mmol/L Chloride mmol/L
CMC 0.5% 147.8 ± 0.5 4.9 ± 0.2 112.8 ± 0.8
250 mg/kg 148.5 ± 2.2 4.8 ± 0.2 109.5 ± 2.8
500 mg/kg 149.5 ± 3.2 4.9 ± 0.4 111.5 ± 2.0
1000 g/kg 151.0 ± 2.4 5.2 ± 0.3 115.8 ± 1.7
Female
CMC 0.5% 147.8 ± 0.6 4.9 ± 0.1 112.3 ± 1.7
250 mg/kg 147.8 ± 3.1 4.9 ± 0.1 109.3 ± 3.5
500 mg/kg 147.3 ± 1.6 5.3 ± 0.4 115.3 ± 3.7
1000 mg/kg 152.3 ± 1.7 5.4 ± 0.3 120.0 ± 2.5
Values are expressed as Mean ± SEM and One-way ANOVA was used for the analysibehaviour (no sign of changes in eyes, fur, skin, respir-
ation, sedation, convulsion) were observed throughout
14 days. The biochemical measurement of blood serum,
clinical observation and histo-pathological estimation of
the kidney and liver revealed that there are no significant
differences (P > 0.05) between treated groups and normal
control group as shown in (Tables 1, 2, 3), (Figure 1).
Antiulcer characteristics
The gastro-protective effects of HPTP chalcone was esti-
mated against indomethacin induced gastric ulcer in rats
(Table 4) in terms of pH of gastric, mucus barrier, ero-
sive gastric damage area and percentage of inhibition.
Pre-treatment with 50 mg/kg and 100 mg/kg of HPTP
were found to inhibit stomach lining injury induced by
indomethacin. This inhibition appeared in low dose and
high dose (65.4% and 74.4%) respectively. Thus, this
study revealed that HPTP can decrease the acidity sig-
nificantly (p < 0.05) which plays a major role in stimulat-
ing stomach ulcer. Gastric mucus layer that is covering
the gastric lining plays an important role in preserving
the inner layer of stomach from exogenous aggressive
factors. In this study it has been shown that HPTP sig-
nificantly enhanced the gastric mucus production at low
dose and high dose administration (Table 4).
The macroscopic sections of stomachs showed signifi-
cant differences between groups (Figure 2). Rats in the
HPTP treated groups (3 and 4) significantly reduced
areas of gastric lesions compared to rats in group 2.
Indomethacin induced gastric lesions were significantly
reduced in term of size and severity in rats pre-treated
with omeprazole as shown in Figure 2.
Antioxidant properties
The enzymatic and non-enzymatic parameters that play
important role in protecting the gastric mucosa from
damage. This study evaluated the effect of ulcer induc-
tion on some of these parameters (GPx, SOD, PGE2 and
MDA), thus the effect of HPTP pre-treatment on thesele rats) in acute toxicity studies
CO2 mmol/L An.gap mmol/L Urea mmol/L Creatinine μmol/L
15.5 ± 0.78 24 ± 0.4 8.3 ± 0.6 31.5 ± 1.6
15.6 ± 1.3 24.8 ± 0.9 6.2 ± 0.8 29.3 ± 1.6
14.1 ± 0.5 24.8 ± 1.0 8.2 ± 1.3 30.0 ± 0.7
13.8 ± 0.4 27 ± 1.9 11.3 ± 1.1 35.3 ± 2.3
13.4 ± 0.9 26.8 ± 0.5 7.2 ± 0.4 29.3 ± 1.3
16.7 ± 1.2 27.3 ± 1.7 6.7 ± 1.1 30.0 ± 1.2
14.3 ± 0.4 29.3 ± 1.0 7.8 ± 1.1 25.5 ± 2.0
14.0 ± 0.8 28.3 ± 3.0 6.6 ± 1.2 28.5 ± 2.3
s.
Table 2 Effects of HPTP on liver functions in rats (male and female) in acute toxicity studies
Animals T. protein (g/L) Albumin (g/L) Globulin (g/L) T. billirubin (μmol/L) ALP (IU/L) ALT (IU/L) AST (IU/L)
Male
CMC 0.5% 58.5 ± 2.50 14.0 ± 0.8 45.0 ± 2.0 3.3 ± 0.3 97.5 ± 3.6 55.8 ± 1.5 171.0 ± 5.5
250 mg/kg 53.0 ± 2.6 13.3 ± 1.4 47.5 ± 2.8 4.3 ± 0.5 87.0 ± 8.3 46.5 ± 2.2 183.5 ± 11.2
500 mg/kg 55.8 ± 0.9 14.8 ± 0.6 54.8 ± 2.7 3.3 ± 0.3 101.3 ± 8.1 56.3 ± 3.7 189.3 ± 6.8
1000 mg/kg 55.8 ± 1.1 14.8 ± 1.1 52.8 ± 3.1 4.0 ± 0.4 105.5 ± 6.7 59.3 ± 4.9 176.3 ± 14.5
Female
CMC 0.5% 59.8 ± 1.8 13.0 ± 0.4 42.5 ± 0.9 3.5 ± 0.3 87.5 ± 1.9 55.3 ± 2.8 170.0 ± 4.3
250 mg/kg 58.5 ± 2.5 12.8 ± 1.0 48.0 ± 1.8 4.0 ± 0.4 85.0 ± 3.9 56.0 ± 3.9 189.5 ± 12.7
500 mg/kg 55.0 ± 2.1 15.3 ± 0.6 50.8 ± 3.7 3.8 ± 0.5 93.0 ± 6.4 54.8 ± 2.7 194.5 ± 11.7
1000 mg/kg 55.5 ± 2.3 15.3 ± 0.8 49.0 ± 2.8 3.8 ± 0.5 104.3 ± 4.3 60.0 ± 4.2 215.8 ± 13.0
Values are expressed as Mean ± SEM and One-way ANOVA was used for the analysis.
Table 3 Effects of HPTP on lipid profile levels in blood
serum of male and female rats in acute toxicity studies
Animals Triglyceride T. cholesterol HDL
Male
CMC 0.5% 0.8 ± 0.1 2.1 ± 0.4 2.1 ± 0.1
250 mg/kg 0.7 ± 0.0 2.1 ± 0.2 2.9 ± 0.2
500 mg/kg 0.72 ± 0.1 2.3 ± 0.3 2.4 ± 0.2
1000 mg/kg 1.1 ± 0.1 2.0 ± 0.1 2.6 ± 0.1
Female
CMC 0.5% 0.7 ± 0.1 1.9 ± 0.1 2.0 ± 0.3
250 mg/kg 0.7 ± 0.0 1.8 ± 0.2 1.9 ± 0.2
500 mg/kg 0.7 ± 0.1 1.7 ± 0.2 2.0 ± 0.3
1000 mg/kg 0.7 ± 0.1 1.9 ± 0.1 2.2 ± 0.3
Values are expressed as Mean ± SEM and One-way ANOVA was used for
the analysis.
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methacin group GPx, SOD, and PGE2 were significantly
lower than in normal control (Figures 3, 4 and 5), while
MDA was significantly higher in indomethacin group
than in control (Figure 6). This indicated that indometh-
acin increase the level of MDA and decrease the level of
SOD, GPX and PGE2. As for HPTP, this study revealed
that chalcone significantly increased SOD and PGE2 at
low and high dose, while HPTP chalcone increased GPx
level but no significant differences between indometh-
acin group and HPTP groups. In this study it has been
shown that MDA level in indomethacin group was in-
creased but HPTP chalcone at low and high doses de-
creased MDA that play important role in gastric
ulcerogenic effects (Table 5).
Histological examination
Histological examinations of group 1 indicated that there
was no disruption of the surface epithelium, while the
histological examination showed extensive damage to
the gastric mucosa in group 2, with necrotic lesions
penetrating deeply into the mucosa accompanied by ex-
tensive edema and leukocyte infiltration of the submuco-
sal layer (Figure 7). Group 3 exhibited moderate
disruption of the surface epithelium, with edema and
leukocyte infiltration of the submucosal layer, and group
4 showed a mild disruption of the surface epithelium
with edema and leukocyte infiltration into the submuco-
sal layer. Group 5 showed mild edema and leukocyte in-
filtration of the submucosal layer, but no disruption of
the surface epithelium. These results demonstrated that
the HPTP exerted cytoprotective effects in a dose-
dependent manner (Figure 5).
(Figure 8) shows the Periodic Acid-Schiff (PAS) stain.
The gastric mucosa in animals pretreated with HPTP or
omeprazole (group 3–4) displayed increased PAS stain-
ing intensity compared to the rats in group 2, indicatingan increase in the glycoprotein content of gastric mu-
cosa in pretreated rats (Figure 8).
The expression of the HSP70 and TGFβ protein in the
gastric mucosa was down-regulated in section of ulcer-
ated stomach tissue while it was up regulated in the
groups pre-treated with 50, 100 mg/kg of HPTP and
20 mg/kg of omeprazole respectively (Figures 9 and 10).
Immunohistochmical analysis of Bax protein expres-
sion in gastric tissue of ulcerated stomach showed up
regulation of Bax protein in injured area while it was
down regulated in groups pre-treated with 50, 100 mg/kg
of HPTP and 20 mg/kg of omeprazole respectively
(Figure 11).
Discussion
Chalcones are widely found in the plants and produce
antioxidant, antimicrobial, anticancer and antibiotic
properties. Their availability in different plant sources as
well as their pharmacological values and low toxicity re-
sulted in the interest of scientists and industries [17].





Figure 1 Effects of HPTP on Histology of liver and kidney in acute toxicity testing. Rats treated with vehicle (1A and 1B), rats treated with
250 mg/kg HPTP (1C and 1D), rats treated with 500 mg/kg HPTP (1E and 1F), rats treated with 1000 mg/kg HPTP (1G and 1H). There were no
significant difference in the histology of liver and kidney between treated and control groups (H&E stain) (magnification 20x).
Dhiyaaldeen et al. BMC Veterinary Research  (2014) 10:961 Page 4 of 14
Table 4 Effects of HPTP on gastric ulcer induced by indomethacin in rats
Pre-treatment (5 ml/kg) Gastric pH Mucus barrier
μg/g tissue
Ulcer area (mm2) % inhibition
Normal (0.5% CMC) 6.36 ± 0.24* 27.67 ± 1.97* ---- ----
Indomethacin 100 mg/kg 2.17 ± 0.07 7.17 ± 0.21 112.32 ± 11.74 ----
HPTP 50 mg/kg 3.10 ± 0.18* 21.97 ± 1.32* 38.88 ± 2.88* 65.4
HPTP 100 mg/kg 4.52 ± 0.17* 27.48 ± 1.08* 28.80 ± 2.28* 74.4
Omeprazole 20 mg/kg 5.7 ± 0.30* 28.43 ± 1.45* 10.08 ± 1.76* 91.04
Values are expressed as Mean ± SEM. (*) indicates significant at P < 0.05 versus indomethacin (ulcerated) group with pre-treatment groups.
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this study revealed that all doses (250,500,1000 mg/kg)
of (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone) (HPTP)
chalcone are safe because none of the animals produced
toxic signs and symptoms and none died during the
study period. Moreover there are no significantC
E
A
Figure 2 Macroscopic evaluation of the gastric lesions in rats. The nor
indomethacin treated group (B) produced visible hemorrhagic necrosis o
(C) shows moderate injuries in the gastric mucosa (black arrow) and little
little flattened (white arrow) in gastric mucosa and fewer injuries were o
flattened (white arrow) of gastric mucosa and few and small injuries in tdifferences in biochemical parameters of liver and kid-
ney. Histology revealed no nephrotoxic or hepatotoxic
effect. Similarly, several researcher used various synthe-
sized Schiff base compound and showed no nephrotox-
icity or hepatotoxicity and the biochemical parameter
are within the normal rang [7-9]. Based on theseD
B
mal control group (A) shows no injury of gastric mucosa. The
f gastric mucosa (black arrow). Rats pre-treated with 50 mg/kg HPTP
flattened (white arrow). Rats pretreated with 100 mg/kg HPTP (D) shows
bserved (black arrow). The omeprazole treated group (E) has more


























Figure 3 Effects of HPTP on glutathione peroxidase activity in
indomethacin induced erosive gastric damage in rat stomach.
Values are expressed as Mean ± S.E.M. (*a) indicates significance at
P < 0.05 versus indomethacin with HPTP chalcone and (*) at P < 0.05
versus indomethacin with normal control.
Figure 5 Effect of HPTP on Prostaglandin E2 activity. Values are
expressed as Mean ± S.E.M. (*a) indicates significance at P < 0.05 versus
indomethacin with HPTP chalcone and (*) at P < 0.05 versus
indomethacin with normal control.
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periment was of no toxicity to rats. Moreover, this study
showed that chalcone was able to produce more ulcer
inhibition in gastric tissue in rats (65.4% in low dose and
74.4% in high dose administration of chalcone. Kyoguku
et al. [18] conducted their study with the aim of compar-
ing antiulcerogenic effects of different chalcones and
therefore did not report on the protective mechanism of
chalcone. This study revealed that this compound pro-
duces its dose dependent protective effect through the
increase in the gastric wall mucus and as well as increas-
ing the PH and antioxidant properties of mucosa. With
the consistence of the result of our study, previous
studies also showed anti ulcerogenic effects of various
synthesized compound against ethanol-induced gastric
ulcerogenic damage and showed increased in gastric wall
mucus [19]. In terms of antioxidant properties, HPTPFigure 4 Effect of HPTP on SOD enzyme in indomethacin
induced erosive gastric damage in rat stomach. Values are
expressed as Mean ± SEM. (*) indicates significance at P < 0.05
versus indomethacin with HPTPchalcone and (*a) at P < 0.05 versus
indomethacin with normal control.chalcone significantly showed to be capable of reducing
lipid peroxidation as well as improving SOD and PGE2
and GPX levels. In this study significant difference was
observed in terms of SOD and PGE2 levels between the
experimental groups. It was previously reported that the
administration of indomethacin at doses as low as 25 mg/
kg resulted in significant decrease in GPx levels in rats
[20,21]. The higher doses of indomethacin were used in
this study and significant reduction in GPx was observed
in this group compared with the normal controls and
treated groups. These findings confirm the antiulcerFigure 6 Effect of pre-treatment with HPTP and omeprazole
followed by indomethacin (100 mg/kg) on Malondialdehyde
releasing. Values are expressed as Mean ± S.E.M. (*a) indicates
significance at P < 0.05 versus indomethacin with normal control and
(*) at P < 0.05 versus HPTP chalcone.
Table 5 SOD, GPx, PGE2 and lipid peroxidation(MDA) properties of HPTP in indomethacin-induced gastric
lesions in rats
Pre-treatment (5 ml/kg) GPX (μmol/mg) SOD (μmol/mg) PGE2 (U/ml) MDA (nmol/ml)
Normal (0.5% CMC) 33.72 ± 1.80*a 130.06 ± 11.58*a 681.03 ± 37.83*a 4.12 ± 0.37*a
Indomethacin 100 mg/kg 20.02 ± 0.97 67.55 ± 4.63 163.07 ± 11.68 8.78 ± 0.78
HPTP 50 mg/kg 22.33 ± 1.47 112.78 ± 3.31* 410.52 ± 16.38* 4.6 ± 0.67*
HPTP 100 mg/kg 25.22 ± 1.93 128.42 ± 7.98* 419.85 ± 28.92* 2.25 ± 0. 59*
Omeprazole 20 mg/kg 33.23 ± 1.11* 125.16 ± 1.53* 653.77 ± 19.99* 1.79 ± 0.19*
Values are expressed as Mean ± SEM. (*a) indicates significance at P < 0.05 versus normal control with indomethacin group, (*) P < 0.05 versus indomethacin with all
treated groups. GPx = Glutathione peroxidase, SOD = Superoxide dismutase, PGE2 = Prostaglandin E2, MDA = Estimation of lipid peroxidation level.
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of oxidative stress through increase in production of SOD
and PGE2 and GPx levels. It has been revealed that gastric
hyperacidity and ulceration of the stomach mucosa can be
to be mediated largely through the generation of excessive
reactive oxygen species and free radicals, especially theA B
C D
E
Figure 7 Histological evaluation of gastric lesions in sections stained
normal tissue epithelium. Indomethacin group (B) shows disruption of surf
deep into mucosa layer (white arrow) wide edema (brown arrow) and leuk
reduction of submucosal edema (brown arrow), mild to moderate disruptio
Omeprazole group (E) shows mild disruption of the surface epithelium (blu
leukocyte (H&E stain, magnification 20x).hydroxyl radical which leads to oxidative stress [22]. It is
proven that antioxidants have anti-ulcerogenic properties
through neutralization of free radicals and breakdown the re-
active oxygen species (ROS) chain process [23]. Odabasoglu
et al. (2006) also reported that indomethacin administration
resulted in significant reduction in SOD levels in rats. Thiswith Hematoxylin & Eosin (10X). Normal control group (A) has
ace epithelium with hemorrhage (black arrow) and the lesions infiltrate
ocyte infiltration (red arrow). HPTP pre-treated groups (C & D) shows
n of mucosa epithelium (blue arrow) few infiltration of leukocyte.





Figure 8 Histological evaluation of gastric glycoproteins in sections stained with PAS. The magenta color in the apical epithelial cells
shows glycoprotein accumulation in the gastric glands (blue arrow). Normal control group (A), indomethacin treated group (B), HPTP pre-treated
groups (C & D) and omeprazole pre-treated group (E) (PAS stain, magnification 20x).
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significant decrease in SOD levels in rats with indo-
methacin induced gastric ulcer. This study also revealed
that administration of chalcone is capable of increasing
the SOD levels and therefore play a preventive role
against indomethacin-induced gastric ulcerogenic damage.
Koizumi et al. [24] showed that the administration of
30 mg/kg indomethacin resulted in a significant reduction
in the PGE2 levels in rats. This finding was also in line
with the findings of this study. This study revealed that
the most important oxidative mechanisms of indometh-
acin induced erosive gastric damage is related to reduction
of the important antioxidants in the stomach including
SOD as well as PGE2. In the present study, the findings
from histology tests showed the multiple potential effect
of chalcone through reduction in acidity and inhibition
percentage, while in the same time mucus barrier was
increased, which resulted in smaller gastric ulcer area inchalcone groups (Table 4). These properties were also
found to be dose dependent as they improved gastric
mucosal state by increasing dosage. Furthermore, this
study revealed that administration of chalcone at low and
high dose (50 &100 mg/kg body weight) reduced ulcers in
stomach. These findings were in line with the previous
findings in terms of protective mechanisms of chalcone
and flavonoids [25-27]. The findings of this study suggest
the use of chalcone with NSAIDs to reduce the risk of
PUD. Also in a study by Okunrobo and colleagues [28]
they tested the anti-inflammatory and gastro-protective
properties of a synthetic chalcone with different dosages
on rats who compared with the acetylsalicylic acid (ulcer
control) and cimetidine (reference) rat groups. The results
were similar with the results present study terms of gastric
wall mucosal characteristics (ulcer area size, barrier and
inhibition of gastric wall mucosa) and acidity of gastric




Figure 9 Immunohistochmical analysis of HSP70 in gastric tissue induced with indomethacin. (A) Section showed normal mucosal. (B)
Section of ulcerated stomach tissue showed down-regulation of HSP70 in injured area (white arrow). Sections (C, D and E) that pre-treated with
50, 100 mg/kg of HPTP and 20 mg/kg of omeprazole respectively showed up-regulation of HSP70 (white arrow) (magnification 20x).
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indomethacin. Omeprazole as a proton pump inhibitors
(PPIs) are broadly prescribed medications with the control
of gastric acid secretion for the prevention or treatment of
peptic ulcer [29]. Omeprazole can suppress the gastric
acid secretion through the H+,K + −ATPase [30]. It has
been discovered that the H+,K + −ATPase as gastric cell
proton pump transfers H+ in exchange for luminal K+ to
generate a highly acidic environment in the stomach that
is responsible for gastric acid secretion [31]. Lastly indo-
methacin as a potent inhibitor of prostaglandins synthesis
diminishes the protective effect of PGE2 on mucosa of
gastric wall [22].
Conclusion
Acute toxicity tests did not show any sign of morbidity
or mortality up to 1000 mg/kg of HPTP. Rats pre-
treated with 50 mg/kg or 100 mg/kg of HPTP before ad-
ministration of 100 mg/kg of indomethacin significantly
protect erosive gastric mucosal damage compared toulcerogenic control group. Histologic findings showed
that HPTP remarkably protect gastric mucosa compared
to ulcerogenic control group. The gastroprotective ef-
fects of HPTP could be attributed to increase in pH and
mucus content of gastric content, increase endogenous
enzymes and PGE2, and decrease in MDA level in gas-
tric homogenate, over-expresion of HSP70 and TGF-β
proteins, and down-expression of Bax protein.
Methods
This experiment was approved by the animal ethic com-
mittee of animal experimentation, Faculty of Medicine,
UM, ethic NO.PM/29/06/2012/SMD (R).
Animals
Adult healthy Sprague Dawley (SD) rats were used for
gastro-protective and (ICR) mice for acute toxicity
evaluation. The animals were supplied from the animal
house, Faculty of Medicine, UM, Kuala Lumpur. All ex-




Figure 10 Immunohistochmical analysis of TGF-β protein expression in gastric tissue of rat induced with indomethacin. (A) Section
shows normal mucosal area and express regulated of TGF-β (red arrow). (B) Section of ulcerated stomach tissue ashowed down-regulation of
TGF-β almost non-existent in injured area (white arrow). Sections (C, D and E) that pre-treated with 50, 100 mg/kg of HPTP and 20 mg/kg of
omeprazole respectively found the up-regulation of TGF-β (red arrows) (magnification 20x).
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were housed at least 3 days before experiment under
standard condition (individual plastic cages with wide
mesh bottom for preventing coprophagia and temperature
of 24 ± 2°C and lighting). Animals were fed with commer-
cial diet and tap water [32]. The experimental animals were
sacrificed after being anesthetized by 0.1 ml/100 gram body
weight of a mixture of ketamine (8.75 ml, 100 mg/ml) and
xylazine ( 1.25 ml, 100 mg/ml) [33,34].
Chemicals
(1-(4-hydroxy-phenyl)-3-m-tolyl-propenone (HPTP) chal-
cone was obtained from Pharmacy Department, Faculty of
Medicine, UM. HPTP was suspended in 5 ml/kg body
weight of 0.5% w/v of Carboxylmethylcellulose (CMC)30 minutes prior to the experiment. Indomethacin was
purchased from sigma chemicals and used as ulcerogenic
agent to induce gastric ulcers. Omeprazole was used as
standard ulcer preventing agent, it was provided from
University Malaya Medical Centre. Experimental chemi-
cals were suspended in 0.5% carboxyl methyl cellulose
(CMC) 30 minutes before feeding the rats and were ad-
ministered orally by orogastric tube. All chemicals for la-
boratory experimentation were purchased from sigma
chemical. Laboratory kits for prostaglandin E2 (PGE2),
Glutathione peroxidase (GPX), superoxide dismutase
(SOD) and Malondialdehyde (MDA) were purchased from
Cayman chemicals. Blood samples were analysed in the





Figure 11 Immunohistochmical analysis of Bax protein expression in gastric tissue of rat induced with indomethacin. (A) Section shows
normal mucosal area and express down-regulated of Bax. (B) Section of ulcerated stomach tissue appears up-regulation of Bax protein in injured
area (white arrow). Sections (C, D and E) that pre-treated with 50, 100 mg/kg of HPTP and 20 mg/kg of omeprazole respectively found the Bax
protein expression was down-regulated (magnification 20x).
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This test was performed to identify the safe dose for
HPTP based on the OECD 423 guideline. HPTP was ad-
ministered at 250, 500 and 1000 mg/kg body weight. All
mice were deprived from food for 24 hours and water
was withdrawn from the mice 2 hour before commence-
ment of the experiment. Forty mice were equally divided
in to four groups 5 male and female mice each:
Group 1 (normal control) received vehicle (5 ml/kg CMC)
Group 2 received (a dosage of 250 mg/kg) HPTP chalcone
Group 3 received 500 mg/kg HPTP chalcone
Group 4 received 1000 mg/kg HPTP chalcone
A single dose of the compound was administered to
mice. Following administration , the animals were ob-
served for abnormal behaviour (sedation, convulsions,
respiratory distress, salivation, changes in skin, fur andetc.) for first 3 hours continuously and at 24 hours for
mortality and at least once daily thereafter for 14 days.
Feeding was replaced approximately 3–4 hours after
dosing [9]. The animals were sacrificed on the 15th day;
blood sample was collected for biochemical assay includ-
ing liver and kidney function. Liver and kidneys were
preserved in buffered formalin 10% for 24 hours for
histological study.
Gastro-protective activity
In this study, indomethacin as a non-steroidal anti-
inflammatory drug (NSAID) was used as ulcerogenic
agent [35]. A total of 30 adult female SD rats weighting
(200–250 gram) were assigned to 5 groups. All groups
were fasted for 24 hours prior to the experiment, but
allowed free access to drinking water until 2 hours be-
fore beginning the experiment. Group 1 and 2 were re-
ceived CMC. HPTP at either dose of (50, 100 mg/kg
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respectively. Omeprazole was administered to group 5 at
a dose of 20 mg/kg. After 30 minutes all groups, except
group 1, received indomethacin (100 mg/kg Six hours
later, the animals were anesthetized by ketamine and
xylazine then sacrificed by cervical dislocation [36]. The
stomachs were excised quickly after tying the pyloric
and cardiac ends and were kept in normal saline. The
protective effects of HPTP were, as well, compared with
gastric ulcerogenic model observed in rats that were
treated with PPI (omeprazole).
Measurement of gastric acidity:
The gastric juice was collected and centrifuged at
4000 rpm for 10 minutes in room temperature. The
supernatant was used to measure the acidity of gastric
juice by titration with 0.1 N NaOH solution using digital
PH meter and the acid content was measured in mEq/L [7].
Evaluation of macroscopic gastric mucosal lesions
The stomach was opened out along the greater curva-
ture and washed slightly with normal saline. The erosive
gastric damage formed on the inner surface of the stom-
ach were counted under a dissecting microscope (1.8X)
with square –grid eye piece to assess the ulcers. Ulcer
area was then calculated based on the formula proposed
by Salga et al. [37]. The lesion area was measured as
(lesions area = lesion number x 1.8 x4).
%ð Þ Inhibition ¼ Mean ulcer area controlð Þ
−Mean treatment=mean ulcer area controlð Þ
 100:
Mucus barrier estimation
Gastric wall mucus was determined based on the
modified procedure of Corne et al. [38]. The glandular
portion of the stomach was immersed in 10 ml of 0.1%
alcian blue solution which contains 1 g/L alcian blue,
0.16 M/L sucrose and sodium acetate 0.05 M/L, PH
adjusted to 5.6 with HCL for 2 hours. The sample was
then washed by 0.25 M/L sucrose for 15 minutes and
then washed for 45 minutes to remove unbounded dye.
Magnesium chloride (MgCl2) (10 ml of 0.5 M/L) was
used to elute bound dye. For this purpose the sample
was immersed in MgCl2 for 2 hours. The resulting blue
solution was mixed and shaken with equal volume
of diethyl ether for 2 min. The resulting emulsion
was then centrifuged at 3000 rpm for 10 min. at room
temperature. The absorbance of the aqueous layer
was recorded at 605 nm using spectrophotometer. The
standard curve was used to calculate the quantity of the
extracted alcian blue per gram of glandular tissue (as μg
alcian blue/gram tissue weight).Biochemical investigation of stomach tissues
Tissue homogenate was prepared by homogenizing 0.5
gram of gastric tissue on ice with 5 ml of phosphate
buffered saline (PBS) using an ultra- turrax homogenizer
for 15 minutes. The mixture was then centrifuged using
refrigerated centrifuge at 4°C for 20 minute. The super-
natants were collected in eppendorf tubes and used for
enzymatic and non enzymatic assessments of the stom-
ach tissue. SOD, GPX and MDA were assessed using the
Cayman’s kits (Cayman chemical, USA) according to
the manufacture’s protocols. While for measurement
of Prostaglandin E2 (PGE2) stomach mucosal tissue
(100 mg) was homogenized in1 ml homogenization
buffer, which includes 0.1 phosphate buffer, PH7.4,
1 mM EDTA and 10 μM indomethacin. The sample
was then centrifuged at 8000 rpm for 10 minutes to
eliminate the particular matter. The supernatant was
transferred to a clean eppendorf tube to evaluate
PGE2 using prostaglandin E2 enzyme immune assay
kit (Cayman Chemical Co.).
Histological examinations
Stomach tissue samples were fixed in 10% buffered
formalin for 48 hours and were then dehydrated by
washing by ascending grades of ethanol. Samples were
then cleared with xyline and embedded in paraffin wax.
Then 5 μm thick slides were sectioned and stained with
haematoxylin and eosin using conventional method and
examined by light microscope. Following the method of
McManus & Mowry [39] the glandular portion of the rat
stomach sections were stained with Periodic Acid-Schiff
(PAS) to observe the changes of glycoprotein.
Immunohistochemistry
The immunohistochemical staining was conducted ac-
cording to manufacturer’s protocol (Dako Cytomation,
USA) to detect immunohistochemical antibodies such as
HSP70, Bax and TGF-β. The tissue sections were place
on Poly-L-lysine coated slides, then kept in oven at 60
(C°) for 24 hours in order to increase section adherence
to the slide. The slides were deparaffinized by xylene
and rehydrated by graded concentrations of alcohol,
then placed in retrieval solution and incubated in micro-
wave at high power for 15 min., the slides were cooled
then washed with wash buffer. After that the tissue was
covered with the (HSP70 1:1000), (TGF 1: 1000), and
(Bax 1:50) biotinylated primary antibody and incubated
for 30 minutes in dark and humid place, followed by
rinsing the slides gently with wash buffer. Subsequently
the tissue sections were covered with streptovidin
peroxidase and incubated for 30 minutes, then rinsed
gently by wash buffer and placed in humid and dark box.
After wards the slides were covered with Diaminobenzidine
(DAB) chromogen solution and incubated for10 minutes
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water. The next step is counter staining with Hematoxylin
for 5 minutes followed by washing with tap water until
the blue colour disappeared. Finally the tissue sections
were dehydrated by graded alcohol, cleared by xylene and
mounted as mentioned in the last steps in H&E staining
method. The positive result was appeared brown in color.
Statistical analysis
Descriptive analysis was performed for continuous vari-
ables and these variables were shown as mean ± standard
error of measurement (SEM). One-way analysis of vari-
ance (ANOVA) was used to analyse the study variables
between experimental groups in normally distributed
data. P value less than 0.05 was considered as statisti-
cally significant at the confidence level of 95%.
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